CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion

被引:29
作者
Hombach, A
Heuser, C
Marquardt, T
Wieczarkowiecz, A
Groneck, V
Pohl, C
Abken, H
机构
[1] Univ Cologne, Lab Tumor Genet, Dept Internal Med 1, Innere Med Klin 1, D-50931 Cologne, Germany
[2] St Elisabeth Krankenhaus Koln Hohenlind, Cologne, Germany
关键词
D O I
10.4049/jimmunol.167.2.1090
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells engrafted by a recombinant immunoreceptor with predefined Ag specificity can efficiently lyse Ag-positive target cells in a MHC Ag-independent manner. It is yet unresolved how receptor-grafted CD4(+) T cells contribute to MHC Ag-independent target cell lysis. To address this issue, we grafted isolated CD8(+) and CD4(+) T cells from the peripheral blood with recombinant anti-carcinoembryonic Ag and anti-CD30 receptors, respectively. Cytotoxicity analyses revealed that grafted CD4(+) T cells exert cytolysis of Ag-positive target cells with an efficiency similar to that of grafted CD8(+) T cells. Lysis by receptor-grafted CD4(+) T cells is Ag specific and is inhibited by blocking the target Ag or the Ag binding site of the recombinant receptor. Both Fas-sensitive and Fas-resistant target cells are lysed with equal efficiency, and lysis of Fas-sensitive target cells is not blocked by an anti-Fas ligand Ab, indicating that cytolysis by receptor-grafted CD4(+) T cells is independent of the Fas pathway. We conclude that cytolysis by CD4(+) T cells equipped with a recombinant immunoreceptor is MHC Ag and Fas independent and likely to be mediated by perforin present in receptor-grafted CD4(+) T cells.
引用
收藏
页码:1090 / 1096
页数:7
相关论文
共 24 条
[1]   Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells? [J].
Abken, H ;
Hombach, A ;
Reinhold, U ;
Ferrone, S .
IMMUNOLOGY TODAY, 1998, 19 (01) :2-5
[2]   Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL [J].
Darcy, PK ;
Haynes, NM ;
Snook, MB ;
Trapani, JA ;
Cerruti, L ;
Jane, SM ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3705-3712
[3]  
ENGERT A, 1990, CANCER RES, V50, P2929
[4]   SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS [J].
ESHHAR, Z ;
WAKS, T ;
GROSS, G ;
SCHINDLER, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :720-724
[5]   Bystander target cell lysis and cytokine production by dengue virus-specific human CD4+ cytotoxic T-lymphocyte clones [J].
Gagnon, SJ ;
Ennis, FA ;
Rothman, AL .
JOURNAL OF VIROLOGY, 1999, 73 (05) :3623-3629
[6]   Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation [J].
Graubert, TA ;
DiPersio, JF ;
Russell, JH ;
Ley, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (04) :904-911
[7]   T cell activation by recombinant FcεRI γ-chain immune receptors:: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition [J].
Hombach, A ;
Heuser, C ;
Gerken, M ;
Fischer, B ;
Lewalter, K ;
Diehl, V ;
Pohl, C ;
Abken, H .
GENE THERAPY, 2000, 7 (12) :1067-1075
[8]   A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA [J].
Hombach, A ;
Koch, D ;
Sircar, R ;
Heuser, C ;
Diehl, V ;
Kruis, W ;
Pohl, C ;
Abken, H .
GENE THERAPY, 1999, 6 (02) :300-304
[9]  
Hombach A, 2000, INT J CANCER, V88, P115, DOI 10.1002/1097-0215(20001001)88:1<115::AID-IJC18>3.0.CO
[10]  
2-E